Gerard Jansen

Dr. Gerard Jansen is a Researcher at the Department of Hematology within Erasmus MC, part of Erasmus University Rotterdam. His work focuses on understanding and treating blood disorders, particularly immune-mediated thrombocytopenias, thrombotic conditions, and platelet dysfunction. He collaborates internationally on clinical trials evaluating novel therapies like rilzabrutinib and daratumumab.

Research interests include exploring the role of intestinal flora in immune thrombocytopenia heterogeneity, biomarkers for stroke outcomes, and functional platelet biology using nanobody-based tools. His recent studies highlight advancements in targeted therapies and diagnostic approaches for complex hematological disorders.

Jansen has contributed to over 50 peer-reviewed publications, including landmark studies on Bruton tyrosine kinase inhibitors and daratumumab treatment efficacy. His work bridges basic science with clinical applications, emphasizing translational research in hematology.